Latest News and Press Releases

BIRMINGHAM, Ala., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Landing, the company behind the first membership for flexible apartment living, has partnered with CLEAR, the secure identity company, to...

DENVER, April 19, 2023 (GLOBE NEWSWIRE) -- Clear Cannabis Inc.™, a national licensor of The Clear™, a legacy cannabis brand of innovative and high quality distilled concentrate products, has...

SAN MATEO, Calif., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Zuora, Inc., the leading SaaS provider of subscription order-to-cash solutions, was named a Leader in the IDC MarketScape: Worldwide Subscription...

– Pivotal Phase 3 Top-Line Results for Bempedoic Acid Expected in the Second and Third Quarters of 2018 –– NDA Submission for LDL-C Lowering Indication for Bempedoic Acid Planned by First Quarter 2019...

ANN ARBOR, Mich., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the lipid management company focused on developing and commercializing complementary oral therapies for...

Presentation and Webcast on Wednesday, November 16, 2016 at 3:00 p.m. Eastern Time ANN ARBOR, Mich., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a pharmaceutical...

ANN ARBOR, Mich., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a pharmaceutical company focused on developing and commercializing oral therapies for the treatment...

1002-035 Study Meets Primary Endpoint of Incremental LDL-C Lowering Added to Atorvastatin 80 mgBempedoic Acid Had No Effect on the PK of Atorvastatin and Was Observed to be Safe and...

Ocean View, Delaware, July 27, 2016 (GLOBE NEWSWIRE) -- Solar Control Window Films Market size is expected to reach USD 1.71 billion by 2024; according to a new research report by Global...

On track to initiate global pivotal Phase 3 studies and CVOT in the fourth quarter Aligned with global regulatory authorities on a consistent definition of statin intolerance Conference...